These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 8054705)
1. Secretion of a latent, acid activatable cathepsin L precursor by human non-small cell lung cancer cell lines. Heidtmann HH; Salge U; Havemann K; Kirschke H; Wiederanders B Oncol Res; 1993; 5(10-11):441-51. PubMed ID: 8054705 [TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor monoclonal antibodies inhibit the growth of lung cancer cell lines. Lee M; Draoui M; Zia F; Gazdar A; Oie H; Bepler G; Bellot F; Tarr C; Kris R; Moody TW J Natl Cancer Inst Monogr; 1992; (13):117-23. PubMed ID: 1327029 [TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells. Guillaume-Rousselet N; Jean D; Frade R Biochem J; 2002 Oct; 367(Pt 1):219-27. PubMed ID: 12241546 [TBL] [Abstract][Full Text] [Related]
4. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines. Teder P; Bergh J; Heldin P Cancer Res; 1995 Sep; 55(17):3908-14. PubMed ID: 7543820 [TBL] [Abstract][Full Text] [Related]
5. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines. Heidtmann HH; Salge U; Abrahamson M; Bencina M; Kastelic L; Kopitar-Jerala N; Turk V; Lah TT Clin Exp Metastasis; 1997 Jul; 15(4):368-81. PubMed ID: 9219725 [TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: impact of an organoselenium compound on growth regulation. El-Bayoumy K; Rose DP; Papanikolaou N; Leszczynska J; Swamy MV; Rao CV Int J Oncol; 2002 Mar; 20(3):557-61. PubMed ID: 11836568 [TBL] [Abstract][Full Text] [Related]
7. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814 [TBL] [Abstract][Full Text] [Related]
8. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins. Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339 [TBL] [Abstract][Full Text] [Related]
9. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. Gilbert JA; Frederick LM; Ames MM Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255 [TBL] [Abstract][Full Text] [Related]
11. Developmental expression of cathepsin L and c-rasHa in the mouse placenta. Hamilton RT; Bruns KA; Delgado MA; Shim JK; Fang Y; Denhardt DT; Nilsen-Hamilton M Mol Reprod Dev; 1991 Dec; 30(4):285-92. PubMed ID: 1751032 [TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of the human delta opioid receptor in lung cancer. Schreiber G; Campa MJ; Prabhakar S; O'Briant K; Bepler G; Patz EF Anticancer Res; 1998; 18(3A):1787-92. PubMed ID: 9673405 [TBL] [Abstract][Full Text] [Related]
13. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice. Onn A; Isobe T; Itasaka S; Wu W; O'Reilly MS; Ki Hong W; Fidler IJ; Herbst RS Clin Cancer Res; 2003 Nov; 9(15):5532-9. PubMed ID: 14654533 [TBL] [Abstract][Full Text] [Related]
14. Hydrogen peroxide degradation and selective carbidopa-induced cytotoxicity against human tumor lines. Gilbert JA; Frederick LM; Pobst LJ; Ames MM Biochem Pharmacol; 2005 Apr; 69(8):1159-66. PubMed ID: 15794936 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer. Dosaka-Akita H; Akie K; Hiroumi H; Kinoshita I; Kawakami Y; Murakami A Cancer Res; 1995 Apr; 55(7):1559-64. PubMed ID: 7882365 [TBL] [Abstract][Full Text] [Related]
16. A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells. Glondu M; Coopman P; Laurent-Matha V; Garcia M; Rochefort H; Liaudet-Coopman E Oncogene; 2001 Oct; 20(47):6920-9. PubMed ID: 11687971 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines. Koshimune R; Aoe M; Toyooka S; Hara F; Ouchida M; Tokumo M; Sano Y; Date H; Shimizu N BMC Cancer; 2007 Jan; 7():8. PubMed ID: 17222343 [TBL] [Abstract][Full Text] [Related]
18. Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma. Joseph B; Ekedahl J; Sirzen F; Lewensohn R; Zhivotovsky B Biochem Biophys Res Commun; 1999 Aug; 262(2):381-7. PubMed ID: 10462484 [TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of magainin analogues against human lung cancer cell lines. Ohsaki Y; Gazdar AF; Chen HC; Johnson BE Cancer Res; 1992 Jul; 52(13):3534-8. PubMed ID: 1319823 [TBL] [Abstract][Full Text] [Related]
20. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer. Kalemkerian GP; Jasti RK; Celano P; Nelkin BD; Mabry M Cell Growth Differ; 1994 Jan; 5(1):55-60. PubMed ID: 8123593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]